Riomet Er is owned by Sun Pharm.
Riomet Er contains Metformin Hydrochloride.
Riomet Er has a total of 1 drug patent out of which 0 drug patents have expired.
Riomet Er was authorised for market use on 29 August, 2019.
Riomet Er is available in for suspension, extended release;oral dosage forms.
The generics of Riomet Er are possible to be released after 01 May, 2035.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US9962336||SUN PHARM||Extended release suspension compositions|| |
(12 years from now)
Drugs and Companies using METFORMIN HYDROCHLORIDE ingredient
Market Authorisation Date: 29 August, 2019
Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic